SCHEMBL15977812

SCHEMBL15977812

c1ccc(-c2ccc(-c3ccccc3-c3c4ccccc4c(-c4ccccc4-c4ccc(-c5ccccc5)cc4)c4cc(-c5ccc(-c6ccccn6)nc5)ccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.44
TGFBR1 P36897 2/20 0.39
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.37
DHODH Q02127 2/20 0.37
GRM5 P41594 1/20 0.37
AXL P30530 1/20 0.36
CDK8 P49336 1/20 0.36
TNIK Q9UKE5 1/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 3/20 0.36
CCR1 P32246 2/20 0.36
CCR5 P51681 2/20 0.36
CCR8 P51685 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
METAP1 P53582 1/20 0.36
BLM P54132 1/20 0.36
HIF1A Q16665 1/20 0.36
DOHH Q9BU89 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977721 0.99 HPGDS (0.45) HPGDSTGFBR1KDRPIK3CADHODH
SCHEMBL15977525 0.92 DHODH (0.42) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL15977811 0.91 DHODH (0.43) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL15977565 0.89 DHODH (0.46) TGFBR1KDRPIK3CADHODHGRM5
SCHEMBL15977472 0.89 HPGDS (0.48) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL15977918 0.89 HPGDS (0.48) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL10300958 0.88 HPGDS (0.49) HPGDSTGFBR1KDRDHODHKDM4E
SCHEMBL30779191 0.88 HPGDS (0.49) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL4951058 0.88 HPGDS (0.49) HPGDSTGFBR1KDRDHODHGRM5
SCHEMBL15977506 0.87 HPGDS (0.46) HPGDSTGFBR1KDRDHODHGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 HPGDS 4636/4885TGFBR1 3114/4885KDR 1909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.